Background: Survivors of cancer in adolescence and young adulthood are at increased risk for subsequent primary neoplasms, but studies using Canadian data are limited. We sought to quantify the risk ...
The MarketWatch News Department was not involved in the creation of this content. -- Cancer Grand Challenges awards five global teams of scientists up to $25m each to take on questions that could open ...
Atezolizumab, combined with chemotherapy, did not improve survival in high-risk triple-negative breast cancer and had higher severe adverse events. A Swedish study found 30% of breast cancers were ...
Cancer before age 50 is rare, but increasing, in the United States and researchers want to know why. A new government study provides the most complete picture yet of early-onset cancers, finding that ...
Cancer is devastating diagnosis, but here all the ways medical cannabis can help Over 2 million people are diagnosed every year in the US and Canada with breast, lung, colorectal, prostate, and skin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results